Assignee
CELLIVERY THERAPEUTICS INC
KR·14 granted patents·3 pending applications·30 citations·filing 2015–2021
Top patents by PatentIndex Score
17 records- 0195US10385103B2Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted Aug 20, 2019·7 cites·16 claims
- 0292US10781241B2Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted Sep 22, 2020·3 cites·11 claims
- 0390US10975132B2Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2019·Granted Apr 13, 2021·2 cites·7 claims
- 0490US10961292B2Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·2 cites·8 claims
- 0588US10787492B2Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted Sep 29, 2020·2 cites·12 claims
- 0687US10689424B2Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2019·Granted Jun 23, 2020·2 cites·13 claims
- 0787US10323072B2Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Jun 18, 2019·2 cites·13 claims
- 0887US10323063B2Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the sameCELLIVERY THERAPEUTICS INC·Filed 2015·Granted Jun 18, 2019·3 cites·5 claims
- 0985US10508265B2Cell-permeable reprogramming factor (iCP-RF) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·3 cites·14 claims
- 1084US10669531B2Cell-permeable Cre (iCP-Cre) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Jun 2, 2020·2 cites·17 claims
- 1184US10662419B2Cell-permeable (ICP) parkin recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·2 cites·18 claims
- 1275US11279743B2Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·0 cites·7 claims
- 1372US10774123B2Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereofCELLIVERY THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·0 cites·12 claims
- 1457US2023357339A1Development of Cell-Permeable Truncated SOCS3 SH2 Domain (CP-SD) Recombinant Protein for Anti-Obesity AgentCELLIVERY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1557US2023073000A1Improved Cell-Permeable Modified Parkin Recombinant Protein for Treatment of Neurodegenerative Diseases and Use ThereofCELLIVERY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1651US2023039219A1Improved Cell-Permeable Nuclear Import Inhibitor Synthetic Peptide for Inhibition of Cytokine Storm or Inflammatory Disease and Use ThereofCELLIVERY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1748US11319546B2Cell-permeable (CP)-Cas9 recombinant protein and uses thereofCELLIVERY THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when CELLIVERY THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →